REN KCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Hedgehog signaling is suggested to be a major oncogenic pathway in medulloblastoma, which arises from aberrant development of cerebellar granule progenitors. Allelic loss of chromosome 17p has also been described as the most frequent genetic defect in this human neoplasia. This observation raises the question of a possible interplay between 17p deletion and the Hedgehog tumorigenic pathway. Here, we identify the human orthologue of mouse REN KCTD11 , previously reported to be expressed in differentiating and low proliferating neuroblasts. Human REN KCTD11 maps to 17p13.2 and displays allelic deletion as well as significantly reduced expression in medulloblastoma. REN KCTD11 inhibits medulloblastoma cell proliferation and colony formation in vitro and suppresses xenograft tumor growth in vivo . REN KCTD11 seems to inhibit medulloblastoma growth by negatively regulating the Hedgehog pathway because it antagonizes the Gli-mediated transactivation of Hedgehog target genes, by affecting Gli1 nuclear transfer, and its growth inhibitory activity is impaired by Gli1 inactivation. Therefore, we identify REN KCTD11 as a suppressor of Hedgehog signaling and suggest that its inactivation might lead to a deregulation of the tumor-promoting Hedgehog pathway in medulloblastoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a tumor suppressor lost in ~30% of human SHH-MBs”
From SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma (2024) · cites this paper as [8]
In the citing paper
“REN/KCTD11 (here REN), the substrate-receptor subunit of the CRL3REN ubiquitin ligase”
From SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma (2024) · cites this paper as [8]
In the citing paper
“REN maps on chromosome 17p, a region frequently deleted in SHH-MB subgroup, and acts as tumor suppressor which, by promoting degradation of HDAC1, inhibits GLI1 activity and represses SHH-MB growth.”
From SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma (2024) · cites this paper as [8]
Citations
Cites
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Altered Neural Cell Fates and Medulloblastoma in Mouse patched Mutants
Goodrich, L. V., Milenković, L., Higgins, K. M., & Scott, M. P. (1997) · Science · doi:10.1126/science.277.5329.1109 · Cited by 1,696
Sonic hedgehog regulates the growth and patterning of the cerebellum
Dahmane, N., & Altaba, A. R. I. (1999) · Development · doi:10.1242/dev.126.14.3089 · Cited by 907
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
The POZ domain: a conserved protein-protein interaction motif.
Bardwell, V. J., & Treisman, R. (1994) · Genes & Development · doi:10.1101/gad.8.14.1664 · Cited by 751
Sasaki, H., Nishizaki, Y., Hui, C.-C., Nakafuku, M., & Kondoh, H. (1999) · Development · doi:10.1242/dev.126.17.3915 · Cited by 715
Gli and hedgehog in cancer: tumours, embryos and stem cells
Ruiz i Altaba, A., Sánchez, P., & Dahmane, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc796 · Cited by 708
Wallace, V. A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80195-x · Cited by 648
The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis
Dahmane, N., Sánchez, P., Gitton, Y., Palma, V., Sun, T., Beyna, M., Weiner, H., & Ruiz i Altaba, A. (2001) · Development · doi:10.1242/dev.128.24.5201 · Cited by 479
Research works printed but not linked: 9
- Dahmane, N. & Ruiz-i-Altaba, A. (1999) Development (Cambridge, U.K.) 126, 3089-3100.
- Dahmane, N., Sanchez, P., Gitton, Y., Palma, V., Sun, T., Beyna, M., Weiner, H. & Ruiz i Altaba, A. (2001) Development (Cambridge, U.K.) 128, 5201-5212.
- Giangaspero F. Bigner S. H. Kleihues P. Pitsch T. & Trojanowski J. (2000) in Pathology and Genetics: Tumors of the Nervous System eds. Kleihues P. & Cavenee W. K. (Int. Agency Res. Cancer Lyon France) pp. 129-137.
- Wetmore, C., Eberhart, D. E. & Curran, T. (2000) Cancer Res. 60, 2239-2246.10786690
- Sasaki, H., Nishizaki, Y., Hui, C., Nakafuku, M. & Kondoh, H. (1999) Development (Cambridge, U.K.) 126, 3915-3924.
- Louro, I. D., Bailey, E. C., Li, X., South, L. S., McKie-Bell, P. R., Yoder, B. K., Huang, C. C., Johnson, M. R., Hill, A. E., Johnson, R. L., et al. (2002) Cancer Res. 62, 5867-5873.12384550
- Ruiz i Altaba, A. (1999) Development (Cambridge, U.K.) 126, 3205-3216.
- Lee, Y., Miller, H. L., Jensen, P., Hernan, R., Connelly, M., Wetmore, C., Zindy, F., Roussel, M. F., Curran, T., Gilbertson, R. J. & McKinnon, P. J. (2003) Cancer Res. 63, 5428-5437.14500378
- Wetmore, C., Eberhart, D. E. & Curran, T. (2001) Cancer Res. 61, 513-516.11212243
Cited by
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Lauth, M., Bergström, Å., Shimokawa, T., & Toftgård, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609699104 · Cited by 782
Targeting Hedgehog — a Cancer Stem Cell Pathway
Merchant, A. A., & Matsui, W. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2846 · Cited by 500
“First, several genetic lesions acting downstream of SMO have been detected in human cancers, such as mutations or loss of heterozygosity of the negative pathway regulators SUFU or RENKCTD11 or amplifications in GLIs (33, 35, 85).”
BackgroundHedgehog beyond medulloblastoma and basal cell carcinoma
Teglund, S., & Toftgård, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.003 · Cited by 426
“REN Loss-of-function Medulloblastoma [429]”
BackgroundEpigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K.-H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 422
“However, REN is often deleted in human medulloblastoma [63], resulting in increased levels of HDAC1 and Gli1, and subsequent deregulation of Hh signaling in neural progenitors and tumor cells [62].”
BackgroundThe Gli code: an information nexus regulating cell fate, stemness and cancer
Ruiz i Altaba, A., Mas, C., & Stecca, B. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.06.007 · Cited by 384
“Even if the Gli proteins survive these attacks, other proteins prevent them from entering the nucleus: Sufu and Ren, two unrelated proteins, then sequester them in the cytoplasm and inhibit their nuclear function [84-86].”
BackgroundBeauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y.-C., Peaceman, D., Özdemirli, M., Rodriguez, O., Macdonald, T. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42874 · Cited by 351
“Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).”
BackgroundConcerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
Ferretti, E., De Smaele, E., Miele, E., Laneve, P., Po, A., Pelloni, M., Paganelli, A., Di Marcotullio, L., Caffarelli, E., Screpanti, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.172 · Cited by 332
“Loss of function of these genes has been reported to cooperate with Hh signalling for MB growth (Wetmore et al, 2001; Di Marcotullio et al, 2004; Ferretti et al, 2005; Briggs et al, 2008).”
BackgroundMethodInfluentialSelf-citationCanettieri, G., Di Marcotullio, L., Greco, A., Coni, S., Antonucci, L., Infante, P., Pietrosanti, L., De Smaele, E., Ferretti, E., Miele, E., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2013 · Cited by 322
“We report that Gli deacetylation is regulated by a multiprotein module involving HDAC and an E3 ubiquitin ligase, formed by Cullin3 and REN KCTD11 , a Gli antagonist encoded by a gene frequently deleted in human medulloblastom”
BackgroundSelf-citationThe Origins of Medulloblastoma Subtypes
Gilbertson, R. J., & Ellison, D. W. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151518 · Cited by 294
Medulloblastoma in childhood: new biological advances
Crawford, J. R., MacDonald, T. J., & Packer, R. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70289-2 · Cited by 286
Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination
Marcotullio, L. D., Ferretti, E., Greco, A., De Smaele, E., Po, A., Sico, M. A., Alimandi, M., Giannini, G., Maroder, M., Screpanti, I., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1510 · Cited by 275
Self-citationContext-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
Stecca, B., & Ruiz i Altaba, A. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp052 · Cited by 252
Medulloblastoma: developmental mechanisms out of control
MARINO, S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.11.008 · Cited by 224
Loss of suppressor-of-fused function promotes tumorigenesis
Lee, Y., Kawagoe, R., Sasai, K., Li, Y., Russell, H. R., Curran, T., & McKinnon, P. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210467 · Cited by 218
“Sufu may also function in concert with other proteins such as MIM/BEG4 or REN (KCTD11) (Callahan et al., 2004; Di Marcotullio et al., 2004) to modulate SHH signaling, in a Smo-independent manner.”
BackgroundRoussel, M. F., & Hatten, M. E. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00008-5 · Cited by 201
Mendrzyk, F., Radlwimmer, B., Joos, S., Kokocinski, F., Benner, A., Stange, D. E., Neben, K., Fiegler, H., Carter, N. P., Reifenberger, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8589 · Cited by 213
Polkinghorn, W. R., & Tarbell, N. J. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0794 · Cited by 206
Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer
Spivak-Kroizman, T. R., Hostetter, G., Posner, R., Aziz, M., Hu, C., Demeure, M. J., Von Hoff, D., Hingorani, S. R., Palculict, T. B., Izzo, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-11-1433 · Cited by 202
“hedgehog ligand-independent tumors, they include PTCHinactivating mutations, SMO-activating mutations, or loss of REN, a GLI antagonist, in medulloblastoma (16, 17).”
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation
Gao, N., Ishii, K., Mirosevich, J., Kuwajima, S., Oppenheimer, S. R., Roberts, R. L., Jiang, M., Yu, X., Shappell, S. B., Caprioli, R. M., et al. (2005) · Development · doi:10.1242/dev.01917 · Cited by 193
“…1:200; Santa Cruz), Shh (rabbit, 1:200; Santa Cruz) (Thayer et al., 2003; Niemann et al., 2003; Krebs et al., 2003; Jaskoll et al., 2004) and Ptch1 (goat, 1:200; Santa Cruz) (Canamasas et al., 2003; Niemann et al., 2003; Di Marcotullio et al., 2004; Jaskoll et al., 2004; Sheng et al., 2004).”
Gamse, J. T., Kuan, Y.-S., Macurak, M., Brösamle, C., Thisse, B., Thisse, C., & Halpern, M. E. (2005) · Development · doi:10.1242/dev.02046 · Cited by 185
“KCTD11/REN represses signaling by the secreted protein Hedgehog by preventing the downstream transcription factor GLI from entering the nucleus (Di Marcotullio et al., 2004).”
BackgroundGLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W., Endo, Y., Rubin, J. S., Toretsky, J., & Üren, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806233200 · Cited by 170
Hedgehog-Gli Signaling Pathway Inhibitors as Anticancer Agents
Mahindroo, N., Punchihewa, C., & Fujii, N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801420y · Cited by 166
Hassounah, N. B., Bunch, T. A., & McDermott, K. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0755 · Cited by 176
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
Chen, L., Alexe, G., Dharia, N. V., Ross, L., Iniguez, A. B., Conway, A. S., Wang, E. J., Veschi, V., Lam, N., Qi, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90793 · Cited by 152
Meeting the Challenge of Targeting Cancer Stem Cells
Turdo, A., Veschi, V., Gaggianesi, M., Chinnici, A., Bianca, P., Todaro, M., & Stassi, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00016 · Cited by 162
“…by Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 February 2019 | Volume 7 | Article 16 the frequent somatic mutations in REN gene, which encodes for the E3-ubiquitin ligase complex that mediates the degradation of HDAC1 (Di Marcotullio et al., 2004; Canettieri et al., 2010).”
BackgroundFan, X., & Eberhart, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2264 · Cited by 160
Aberger, F., & Ruiz i Altaba, A. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.05.003 · Cited by 147
“At the level of GLI code, a number of post-translational modifications of GLI proteins play a fundamental role in its control by affecting GLI stability, subcellular localization and DNA binding ability [152–155] (reviewed in [20,40]).”
BackgroundSonic Hedgehog signaling in the mammalian brain
Traiffort, E., Angot, E., & Ruat, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06642.x · Cited by 131
“…tumor suppressors, such as Ren(KCTD11), Numb, or p53, through the suppression of Gli-dependent activation of Hh target genes or Gli1 ubiquitination, may decrease and contribute to the tumorigenic process (De Smaele et al. 2004; Di Marcotullio et al. 2004, 2006, 2007; Stecca and Ruiz i Altaba 2009).”
BackgroundMethylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis
Graves, M. C., Benton, M. C., Lea, R. A., Boyle, M., Tajouri, L., Macartney-Coxson, D. P., Scott, R. J., & Lechner‐Scott, J. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513516529 · Cited by 149
de Bont, J. M., Packer, R. J., Michiels, E. M. C., den Boer, M. L., & Pieters, R. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-059 · Cited by 144
The KCTD family of proteins: structure, function, disease relevance
Liu, Z., Xiang, Y., & Sun, G. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-45 · Cited by 126
“2 has been found in medulloblastoma [19,39].”
BackgroundKCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders
Teng, X., Aouacheria, A., Lionnard, L., Metz, K. A., Soane, L., Kamiya, A., & Hardwick, J. M. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13156 · Cited by 124
Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal
Marcotullio, L. D., Greco, A., Mazzà, D., Canettieri, G., Pietrosanti, L., Infante, P., Coni, S., Moretti, M., Smaele, E. D., Ferretti, E., et al. (2010) · Oncogene · doi:10.1038/onc.2010.394 · Cited by 133
Self-citationCooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma
Briggs, K. J., Corcoran-Schwartz, I. M., Zhang, W., Harcke, T., Devereux, W. L., Baylin, S. B., Eberhart, C. G., & Watkins, D. N. (2008) · Genes & Development · doi:10.1101/gad.1640908 · Cited by 110
“2, REN, has also been implicated in medulloblastoma (Di Marcotullio et al. 2004).”
Kim, Y., Yoon, J. W., Xiao, X., Dean, N. M., Monia, B. P., & Marcusson, E. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3040 · Cited by 122
SHH Pathway and Cerebellar Development
Vaillant, C., & Monard, D. (2009) · The Cerebellum · doi:10.1007/s12311-009-0094-8 · Cited by 132
“In mice, their deletion strengthens the effect of the Ptc heterozygous deletion [73, 82-84 ].”
BackgroundNoncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
Pò, A., Silvano, M., Miele, E., Capalbo, C., Eramo, A., Salvati, V., Todaro, M., Besharat, Z. M., Catanzaro, G., Cucchi, D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.91 · Cited by 118
Self-citationTHE HEDGEHOG PATHWAY AND NEUROLOGICAL DISORDERS
Dellovade, T., Romer, J. T., Curran, T., & Rubin, L. L. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112858 · Cited by 116
“This inhibitory action is perhaps related to RENKCTD11 suppression of Gli1 activity, possibly through inhibiting translocation of Gli1 to the nucleus (Di Marcotullio et al. 2004).”
BackgroundHedgehog Signaling Promotes Medulloblastoma Survival via BclII
Bar, E. E., Chaudhry, A., Farah, M. H., & Eberhart, C. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060066 · Cited by 107
HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors
Fleuriel, C., Touka, M., Boulay, G., Guérardel, C., Rood, B. R., & Leprince, D. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.028 · Cited by 90
“…to human medulloblastoma, in which deletion of the chromosomal 17p region would thus result in the loss of Hedgehog modulators such as REN (Di Marcotullio et al., 2004) and in the loss of regulators of lineage–specific transcription factors, as exemplified above by the HIC1-ATOH1 connection.”
BackgroundDe Smaele, E., Di Marcotullio, L., Moretti, M., Pelloni, M., Occhione, M. A., Infante, P., Cucchi, D., Greco, A., Pietrosanti, L., Todorovic, J., et al. (2011) · Neoplasia · doi:10.1593/neo.101630 · Cited by 92
“The inhibitory role of KCASH2 and KCASH3 on Hh signaling and their reduced expression in primary MB suggested that these proteins could suppress tumor cell growth, similar to KCASH1 that displays an antitumor activity [18,34].”
BackgroundResultInfluentialSelf-citationBehesti, H., & Marino, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.017 · Cited by 101
Pandolfi, S., & Stecca, B. A. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.3 · Cited by 91
KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases
Bayón, Y., Trinidad, A. G., de la Puerta, M. L., del Carmen Rodríguez, M., Bogetz, J., Rojas, A., De Pereda, J. M., Rahmouni, S., Williams, S., Matsuzawa, S., et al. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06537.x · Cited by 85
Signaling pathways in medulloblastoma
Guessous, F., Li, Y., & Abounader, R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21542 · Cited by 83
Functional analysis of Cullin 3 E3 ligases in tumorigenesis
Cheng, J., Guo, J., Wang, Z. P., North, B. J., Tao, K., Dai, X., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.11.001 · Cited by 84
“Keap1 Mutation [86, 87] NRF2, MCM3, IKKβ PGAM5, p62, PALB2 [73, 83-85, 276, 278] KLHL6 Mutation [106] HBXIP [106] KLHL9 Decreased expression [129] Aurora B [255] KLHL16 Mutation [130] MAP1B [261] KCTD6 Decreased expression [127] NA KCTD10 Decreased expression [112] Notch1 [107] KCTD11 Decreased expression [115] HDAC1…”
BackgroundInfluentialRapid Diagnosis of Medulloblastoma Molecular Subgroups
Schwalbe, E. C., Lindsey, J. C., Straughton, D., Hogg, T. L., Cole, M. F., Megahed, H., Ryan, S. L., Lusher, M. E., Taylor, M. D., Gilbertson, R. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2210 · Cited by 81
“2, has also been previously associated with SHH activation in medulloblastoma (19, 33), and was observed in 24% (9/37) of cases.”
BackgroundPentameric Assembly of Potassium Channel Tetramerization Domain-Containing Protein 5
Dementieva, I. S., Tereshko, V., McCrossan, Z. A., Solomaha, E., Araki, D., Xu, C., Grigorieff, N., & Goldstein, S. A. N. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.030 · Cited by 79
Rovida, E., & Stecca, B. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.003 · Cited by 79
Iacovelli, L., Arcella, A., Battaglia, G., Pazzaglia, S., Aronica, E., Spinsanti, P., Caruso, A., Smaele, E. D., Saran, A., Gulino, A., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2285-06.2006 · Cited by 78
“…0.2 g of 12ϫ Gli-binding sequence luciferase reporter plasmid (GliRE) or control luciferase reporter devoid of the Gli binding sites (DeltaGLiRE) (Di Marcotullio et al., 2004) and 0.2 g of the renilla-expressing vector pRL-TK (Promega), reaching the total DNA amount with empty pBluescript…”
InfluentialSelf-citationBrain as a paradigm of organ growth: Hedgehog–Gli signaling in neural stem cells and brain tumors
Stecca, B. A., & Altaba, A. R. I. (2005) · Journal of Neurobiology · doi:10.1002/neu.20160 · Cited by 86
“In addition, new negative regulators of the Hh pathway have been reported, including REN (Di Marcotullio et al., 2004), which antagonizes nuclear localization of Gli1, a process promoted by Dyrk1 (Mao et al., 2000).”
Hedgehog Signaling: Implications in Cancers and Viral Infections
Iriana, S., Asha, K., Repak, M., & Sharma-Walia, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031042 · Cited by 75
“Similarly, a human orthologue of the mouse tumor suppressor gene, RENKCTD11, also antagonizes GLI-mediated transactivation, and its knock-down enhanced HH signaling and cell proliferation in medulloblastoma [42].”
BackgroundArgenti, B., Gallo, R., Di Marcotullio, L., Ferretti, E., Napolitano, M., Canterini, S., De Smaele, E., Greco, A., Fiorenza, M. T., Maroder, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2438-05.2005 · Cited by 73
Self-citationStructural Insights into KCTD Protein Assembly and Cullin3 Recognition
Ji, A. X., Chu, A., Nielsen, T. K., Benlekbir, S., Rubinstein, J. L., & Privé, G. G. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.08.019 · Cited by 83
Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm
Ferretti, E., Smaele, E. D., Marcotullio, L. D., Screpanti, I., & Gulino, A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.10.005 · Cited by 80
Self-citationThe emerging role of the KCTD proteins in cancer
Angrisani, A., Fiore, A. D., Smaele, E. D., & Moretti, M. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00737-8 · Cited by 76
“Furthermore, KCASH1KCTD11 has been shown to be frequently downregulated also by epigenetic modifications both in MB and prostate carcinoma [59, 61, 62].”
BackgroundThe coactivator CRTC1 promotes cell proliferation and transformation via AP-1
Canettieri, G., Coni, S., Della Guardia, M., Nocerino, V., Antonucci, L., Di Magno, L., Screaton, R., Screpanti, I., Giannini, G., & Gulino, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808749106 · Cited by 64
Self-citationDevelopmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications
Izrailit, J., & Reedijk, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.028 · Cited by 64
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Lospinoso Severini, L., Ghirga, F., Bufalieri, F., Quaglio, D., Infante, P., & Di Marcotullio, L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1823967 · Cited by 61
Coni, S., Infante, P., & Gulino, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.001 · Cited by 66
Self-citationMolecular organization of the cullin E3 ligase adaptor KCTD11
Correale, S., Pirone, L., Marcotullio, L. D., Smaele, E. D., Greco, A., Mazzà, D., Moretti, M., Alterio, V., Vitagliano, L., Gaetano, S. D., et al. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.014 · Cited by 55
Self-citationWhi2 is a conserved negative regulator of TORC1 in response to low amino acids
Chen, X., Wang, G., Zhang, Y., Dayhoff-Brannigan, M., Diny, N. L., Zhao, M., He, G., Sing, C. N., Metz, K. A., Stolp, Z. D., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007592 · Cited by 54
Nör, C., Sassi, F. A., de Farias, C. B., Schwartsmann, G., Abujamra, A. L., Lenz, G., Brunetto, A. L., & Roesler, R. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8441-7 · Cited by 53
Protected from the inside: Endogenous histone deacetylase inhibitors and the road to cancer
Marcotullio, L. D., Canettieri, G., Infante, P., Greco, A., & Gulino, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.01.002 · Cited by 55
Self-citationCullin 3 Recognition Is Not a Universal Property among KCTD Proteins
Smaldone, G., Pirone, L., Balasco, N., Di Gaetano, S., Pedone, E. M., & Vitagliano, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126808 · Cited by 52
Smaele, E. D., Fragomeli, C., Ferretti, E., Pelloni, M., Pò, A., Canettieri, G., Coni, S., Marcotullio, L. D., Greco, A., Moretti, M., et al. (2008) · Neoplasia · doi:10.1593/neo.07891 · Cited by 51
“pCMVGliHA was previously described [13].”
BackgroundMethodSelf-citationEmerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Xiong, J. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218886 · Cited by 53
“The region 17p13 accumulates a suite of well-known tumor suppressor genes including HCCS1, DPH1, HIC1, XAF1, KCTD11 and TP53; the exception is USP6, which is an oncogene [17-23] (Fig.”
BackgroundSoon, P. S. H., Libe, R., Benn, D. E., Gill, A., Shaw, J., Sywak, M. S., Groussin, L., Bertagna, X., Gicquel, C., Bertherat, J., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318153ff55 · Cited by 48
Hedgehog pathway inhibitors: a patent review (2009 – present)
Hadden, M. K. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.757304 · Cited by 51
“This region of the genome codes for REN, a tumor suppressor that negatively regulates Hh signaling and its loss results in Hh pathway over-activation and has been implicated as a causative mechanism of MB formation [8,9].”
BackgroundFerretti, E., Marcotullio, L. D., Gessi, M., Mattei, T., Greco, A., Pò, A., Smaele, E. D., Giangaspero, F., Riccardi, R., Rocco, C. D., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209716 · Cited by 50
“D283 and Daoy cells (ATCC, L.G.C., Promochem, Mi, Italy) and cerebellar GCPs isolated from P4 mice were cultured as described previously (Di Marcotullio et al., 2004; Argenti et al., 2005).”
MethodSelf-citationNazio, F., Pò, A., Abballe, L., Ballabio, C., Diomedi‐Camassei, F., Bordi, M., Camera, A., Caruso, S., Caruana, I., Pezzullo, M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02347-7 · Cited by 47
“Cerebellar granule neuron precursors (GNPs) (prepared from CD1 4‐day‐old mice) were isolated and cultured as previously described [6, 22].”
MethodSelf-citationYanglin, P., Zhao, L., Zhiguo, L., Na, L., Haifeng, J., Guoyun, Z., Liang, J., Jun, W., Tao, L., Sun, L., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.02.010 · Cited by 46
Mendrzyk, F., Korshunov, A., Toedt, G., Schwarz, F., Korn, B., Joos, S., Hochhaus, A., Schoch, C., Lichter, P., & Radlwimmer, B. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20304 · Cited by 43
“A number of candidate tumor-suppressor genes have been proposed including LIS1, HIC1, REN, and DLG4 (Adesina et al., 1994; Koch et al., 1996; Di Marcotullio et al., 2004; Lindsey et al., 2004; Mendrzyk et al., 2005).”
BackgroundKCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway
Li, L., Duan, T., Wang, X., Zhang, R.-H., Zhang, M., Wang, S., Wang, F., Wu, Y., Huang, H., & Kang, T. (2016) · Scientific Reports · doi:10.1038/srep20460 · Cited by 43
Hedgehog/Gli Control by Ubiquitination/Acetylation Interplay
Gulino, A., Marcotullio, L. D., Canettieri, G., Smaele, E. D., & Screpanti, I. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394622-5.00009-2 · Cited by 43
Self-citationPathogenic variants in KCTD7 perturb neuronal K+fluxes and glutamine transport
Moen, M. N., Fjær, R., Hamdani, E. H., Laerdahl, J. K., Menchini, R. J., Vigeland, M. D., Sheng, Y., Undlien, D. E., Hassel, B., Salih, M. A., et al. (2016) · Brain · doi:10.1093/brain/aww244 · Cited by 37
Novel Mutation in Potassium Channel related Gene KCTD7 and Progressive Myoclonic Epilepsy
Krabichler, B., Rostasy, K., Baumann, M., Karall, D., Scholl‐Bürgi, S., Schwarzer, C., Gautsch, K., Spreiz, A., Kotzot, D., Zschocke, J., et al. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00710.x · Cited by 39
“KCTD11/REN, for example, represses signalling by the secreted protein Hedgehog by preventing the downstream transcription factor GLI from entering the nucleus (Di Marcotullio et al., 2004).”
BackgroundNegative Regulation of Hedgehog Signaling by Liver X Receptors
Kim, W.-K., Meliton, V., Park, K. W., Hong, C., Tontonoz, P., Niewiadomski, P., Waschek, J. A., Tetradis, S., & Parhami, F. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0453 · Cited by 38
Kogure, M., Takawa, M., Saloura, V., Sone, K., Piao, L., Ueda, K., Ibrahim, R., Tsunoda, T., Sugiyama, M., Atomi, Y., et al. (2013) · Neoplasia · doi:10.1593/neo.131436 · Cited by 38
Cullin3 - BTB Interface: A Novel Target for Stapled Peptides
de Paola, I., Pirone, L., Palmieri, M., Balasco, N., Esposito, L., Russo, L., Mazzà, D., Marcotullio, L. D., Gaetano, S. D., Malgieri, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121149 · Cited by 36
Childhood Medulloblastoma: Current Status of Biology and Treatment
Klesse, L. J., & Bowers, D. C. (2010) · CNS Drugs · doi:10.2165/11530140-000000000-00000 · Cited by 37
Garcia, I., Crowther, A., Gama, V., Miller, C. R., Deshmukh, M., & Gershon, T. R. (2012) · Oncogene · doi:10.1038/onc.2012.248 · Cited by 38
Mancarelli, M. M., Zazzeroni, F., Ciccocioppo, L., Capece, D., Pò, A., Murgo, S., Camillo, R. D., Rinaldi, C., Ferretti, E., Gulino, A., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-172 · Cited by 35
“High levels of 17p13 somatic alterations have been showed in several tumors, distal and independent of the p53 locus [1-4].”
BackgroundSelf-citationSignification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression
Zheng, J., Xiong, D., Sun, X., Wang, J., Hao, M., Ding, T., Xiao, G., Wang, X., Mao, Y., Fu, Y., et al. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0103-1 · Cited by 39
“concluded that Hic1 and Ptch1 tumor suppressors cooperate to silence Atoh1 expression during a critical phase in the granule cell precursors (GCPs) of the cerebellum differentiation in which malignant transformation may lead to medulloblastoma [61].”
BackgroundSmaldone, G., Balasco, N., Pirone, L., Caruso, D., Gaetano, S. D., Pedone, E. M., & Vitagliano, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-46911-4 · Cited by 35
Hedgehog signaling pathway in neural development and disease
Gulino, A., Marcotullio, L. D., Ferretti, E., Smaele, E. D., & Screpanti, I. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.03.017 · Cited by 34
Self-citationDeregulated proliferation and differentiation in brain tumors
Swartling, F. J., Čančer, M., Frantz, A., Weishaupt, H., & Persson, A. I. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-2046-y · Cited by 33
“…is the Potassium channel tetramerisation domain containing 11 (KCTD11, REN) gene, often deleted in MB due to loss of chromosome 17p, expression of which is thought to antagonize SHHinduced proliferation, thus stimulating differentiation of GCPs (Argenti et al. 2005; Di Marcotullio et al. 2004).”
BackgroundSamadani, A. A., Norollahi, S. E., Rashidy‐Pour, A., Mansour‐Ghanaei, F., Nemati, S., Joukar, F., Afshar, A. M., Ghazanfari, S., Safizadeh, M., Rostami, P., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.048 · Cited by 31
Wang, W., Yan, T., Guo, W., Niu, J., Zhao, Z., Sun, K., Zhang, H., Yu, Y., & Ren, T. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00749-4 · Cited by 31
“Mutations within the components of the HH pathway, for example, membrane receptor proteins PTCH1 and SMO [34, 35], non-membrane receptor proteins, such as SUFU [36, 37] and REN (KCTD11) [38], disrupt the feedback loop causing activation of HH pathway and tumor progression.”
BackgroundPathology and Classification of Tumors of the Nervous System
Reifenberger, G., Blümcke, I., Pietsch, T., & Paulus, W. (2010) · Springer eBooks · doi:10.1007/978-3-642-02874-8_1 · Cited by 33
Beauchamp, E. M., & Üren, A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394622-5.00015-8 · Cited by 33
A functional analysis of GABARAP on 17p13.1 by knockdown zebrafish
Komoike, Y., Shimojima, K. Y., Liang, J., Fujii, H., Maegaki, Y., Ōsawa, M., Fujii, S., Higashinakagawa, T., & Yamamoto, T. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.1 · Cited by 30
Mahindroo, N., Connelly, M., Punchihewa, C., Kimura, H., Smeltzer, M. P., Wu, S., & Fujii, N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900106f · Cited by 30
Cullin 3 and Its Role in Tumorigenesis
Chen, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_12 · Cited by 31
Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma
Julian, E., Dave, R. K., Robson, J. P., Hallahan, A. R., & Wainwright, B. J. (2010) · Oncogene · doi:10.1038/onc.2010.101 · Cited by 31
“…cycle regulators such as Ink4c (Zindy et al., 2007), p53/Rb (Marino et al., 2000; Wetmore et al., 2001), Bmi1 (Leung et al., 2004), RenKCTD11 (Di Marcotullio et al., 2004), Brca2 (Frappart et al., 2007) and Parp (Tanori et al., 2008), chemokine receptor Cxcr6 (Sasai et al., 2007), growth…”
Correale, S., Esposito, C., Pirone, L., Vitagliano, L., Gaetano, S. D., & Pedone, E. M. (2013) · Journal of Molecular Recognition · doi:10.1002/jmr.2291 · Cited by 28
“…of an emerging class of multidomain proteins denoted as KCTD (potassium channel tetramerization domain containing proteins) that are involved in important and diversified biological processes (Di Marcotullio et al., 2004; Dementieva et al., 2009; Canettieri et al., 2010; Correale et al., 2011).”
BackgroundMolecular cytogenetic analysis in the study of brain tumors: findings and applications
Bayani, J., Pandita, A., & Squire, J. A. (2005) · Neurosurgical FOCUS · doi:10.3171/foc.2005.19.5.2 · Cited by 28
Matching mice to malignancy: molecular subgroups and models of medulloblastoma
Lau, J., Schmidt, C., Markant, S. L., Taylor, M. D., Wechsler‐Reya, R. J., & Weiss, W. A. (2012) · Child s Nervous System · doi:10.1007/s00381-012-1704-1 · Cited by 31
“Two candidate tumor suppressors, hypermethylated in cancer 1 (HIC1), a POZ domain transcriptional repressor, and RENKCTD11, an E3 ubiquitin ligase component that works with Cullin3 to deacetylate GLI1 and GLI2 [47–49], localize to this region.”
BackgroundPediatric brain tumors: genetics and clinical outcome
Faria, C. C., Miguéns, J., Antunes, J. L., Salgado, D., Nunes, S., Barroso, C., Martins, M. D. C., Nunes, V. M., & Roque, L. (2010) · Journal of Neurosurgery Pediatrics · doi:10.3171/2009.10.peds09240 · Cited by 25
Just Say No to ATOH: How HIC1 Methylation Might Predispose Medulloblastoma to Lineage Addiction
Briggs, K. J., Eberhart, C. G., & Watkins, D. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1904 · Cited by 25
Metadata
- Authors
- Di Marcotullio, L., Ferretti, E., De Smaele, E., Argenti, B., Mincione, C., Zazzeroni, F., Gallo, R., Masuelli, L., Napolitano, M., Maroder, M., Modesti, A., Giangaspero, F., Screpanti, I., Alesse, E., & Gulino, A.
- Affiliations
- Department of Experimental Medicine and Pathology and Pasteur Institute, Cenci Bolognetti Foundation, University La Sapienza, 324 Viale Regina Elena, 00161 Rome, Italy; Department of Experimental Medicine, University of L'Aquila, 67100 L'Aquila, Italy; Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, 00133 Rome, Italy; and Neuromed Institute, 86077 Pozzilli, Italy
- University of Rome Tor Vergata (IT)
- Corresponding author
- Gulino, Alberto
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10833-10838
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC490020
- OpenAlex
- W2164786397
- Semantic Scholar
- 92214e63cd9878d795e5eadb354190c7c7c1b49a
- Cited by
- 179
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 3 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 9 · 2012: 15
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- University of Connecticut
- Karolinska Institutet
- Associazione Italiana per la Ricerca sul Cancro
- Rheinische Friedrich-Wilhelms-Universität Bonn
- RIKEN
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- medulloblastoma, Hedgehog signaling, Gli1, chromosome 17p deletion, tumor suppressor, tumor cell proliferation, xenograft tumor growth
- MeSH terms
- Zinc Finger Protein GLI1, Alleles, Animals, Cerebellar Neoplasms, Chromosomes, Human, Pair 17, Humans, Medulloblastoma, Nerve Tissue Proteins, Transcription Factors, Transferases, Transplantation, Heterologous, Potassium Channels, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, Gene Deletion, Cell Cycle Proteins, Mice, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.